Our previous studies have revealed down-regulation of PER2 in HCC [18], CML [19,20], HNSCC [21], and breast cancer [25] but not in endometrial cancer [26]. This evidence concerns the gene PER2 and chronic myelogenous leukemia, BCR-ABL1 positive.